Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

NCT01399372 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

NETWORK

Sponsor class

Conditions

Chemotherapeutic Agent Toxicity
Cognitive/Functional Effects
Lymphoma
Neurotoxicity
Radiation Toxicity

Interventions

BIOLOGICAL: Rituximab
DRUG: Cytarabine
DRUG: Methotrexate
DRUG: Procarbazine
DRUG: Vincristine
RADIATION: low-dose whole-brain radiation therapy

Sponsor

Radiation Therapy Oncology Group

Collaborators

[object Object]
[object Object]